Top accelerator startups

14,448 startups · 29 programs

Modulari-T

Active · We teach your immune system to attack and cure cancer

8signal of 100 · rising 2
  • went through YCProgram · this site+4
  • team of 4Team size · YC's directory+3.6

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W23

All of W23

About Modulari-T

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

YC batch
W23 · Winter 2023
Status, per YC
Active
Category
Other
Team size
4
Location
Montreal, QC, Canada; San Francisco, CA, USA
Checked
7h ago

YC tags: Gene Therapy, Cell Therapy, Synthetic Biology, Biotech, Oncology

Changes seen

RegionsNov 9, 2026

Same list, in a new order.

RegionsNov 5, 2026

Same list, in a new order.

RegionsNov 2, 2026

Same list, in a new order.

RegionsOct 29, 2026

Same list, in a new order.

Modulari-T in W23: 274 companies, 69% AI

Modulari-T: questions

Which YC batch was Modulari-T in?

Modulari-T was in Y Combinator's Winter 2023 batch (W23).

Is Modulari-T still active?

Y Combinator lists Modulari-T as active.

Where is Modulari-T based?

Modulari-T lists Montreal, QC, Canada; San Francisco, CA, USA as its location on YC's directory.